2张乃铮 Wigley R 等.中国风湿性疾病的流行情况调查[J].中华风湿病学杂志,1997,1(1):31-31.
3赵伟 黄烽.单核因子与脊柱关节病[J].中华风湿病学杂志,2000,4(4):248-248.
4[1]Khan M.A current perspective on ankylosing spondylitis and related spondyloarthropathies[J].J Ind Rheum Asso,1999,7(1)∶16-22.
5[2]Yu D.Spondyloarthropathies[J].Rheum Dis Clin North Am,1998,24(4)∶663-894.
6[3]Marker-Hermann E,Hohler T.Pathogenesis of HLA-B27 positive arthritis:information from clinical materials[J].Rheum Dis Clin North Am,1998,24(4)∶865-882.
7[4]Ferraz M,Tugwell P,Goldsmith C,et al.Meta-analysis of sulphasalazine in ankylosing spondylitis[J].J Rheumatol,1990,17(11)∶1482-1486.
8[5]Dougados M,van der Linden S,Leirisalo-Repo M,et al.Sulphasalazine in the treatment of ankylosing spondylitis:a randomized, multicentre,double-blind,placebo-controlled study[J].Arthritis Rheum,1995,38(5)∶618-627.
9[6]Sampaio-Burros P,Costallat L,Bertolo M,et al.Methotrexate in the treatment of ankylosing spondylitis[J].Scand J Rheumatol,2000,29(3)∶160-162.
10[7]Creemers M,Franssen M,van der Putte L,et al.Methotrexate in severe ankylosing spondylitis:an open study[J].J Rheumatol,1995,22(6)∶1104-1107.
